Activity shown on the vitamin A, E & B5 markets

After the recent incident at a Chinese vitamin A production plant, together with less offers available from Western suppliers, the market is slightly firmer for vitamin A1000, but nothing significant so far. The remainder of Q1 and some early Q2 cover has been taken by now. Vitamin E showed a bit firmer market recently, but it is not following through so far. Q1 and a small portion of Q2 is contracted by now, so there is no new additional demand seen really. It seems that d-calpan has stopped